These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6218562)

  • 1. Absence of beta-lactamase-inducing effect of moxalactam.
    Mouton RP; van Gestel M; Bongaerts GP
    Rev Infect Dis; 1982; 4 Suppl():S527-8. PubMed ID: 6218562
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
    Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
    Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Moxalactam: an inactivator of beta-lactamases].
    Labia R
    Sem Hop; 1983 Jun; 59(26):1959-62. PubMed ID: 6310786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
    Mouton RP; Bongaerts GP; van Gestel MH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():147-52. PubMed ID: 19802978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam: an oxa-beta-lactam antibiotic that inactivates beta-lactamases.
    Labia R
    Rev Infect Dis; 1982; 4 Suppl():S529-35. PubMed ID: 6218563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of moxalactam to beta-lactamase.
    Richmond MH
    Rev Infect Dis; 1982; 4 Suppl():S522-6. PubMed ID: 6218561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
    Fu KP; Neu HC
    J Antimicrob Chemother; 1981 Oct; 8(4):337-41. PubMed ID: 6271727
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.
    Bulger RR; Washington JA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):393-6. PubMed ID: 6448575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
    Dornbusch K; Adamsson L; Gezelius L; Hallander H
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():113-21. PubMed ID: 6460739
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme-mediated resistance of Bacteroides fragilis to moxalactam.
    Maskell JP; Nasu M
    Lancet; 1981 Mar; 1(8222):733. PubMed ID: 6110951
    [No Abstract]   [Full Text] [Related]  

  • 13. Moxalactam: the first of a new class of beta-lactam antibiotics.
    Webber JA; Yoshida T
    Rev Infect Dis; 1982; 4 Suppl():S496-500. PubMed ID: 6218558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production.
    Aldridge KE; Sanders CV; Lewis AC; Marier RL
    J Med Microbiol; 1983 Feb; 16(1):75-82. PubMed ID: 6218305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Moxalactam: a new group of beta-lactams].
    Fourtillan JB
    Sem Hop; 1983 Jun; 59(26):1947-8. PubMed ID: 6310783
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta-lactamase induction in Pseudomonas aeruginosa by cefpiramide and 3 other antipyocyanic cephalosporins].
    Drigues P; Lanau C; Combes T; Roche G; Salhi A
    Pathol Biol (Paris); 1986 May; 34(5):419-23. PubMed ID: 3095775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
    Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.